Dermata Therapeutics, Inc.
Extracted from this filing and checked against the source text.
Dermata Therapeutics, Inc. shareholders approved Approval of the adjournment of the special meeting to the extent there are insufficient votes to approve the reverse stock split proposal at the 2023-02-08 meeting.
Proposal No. 2 : The Adjournment Proposal was approved by a vote of stockholders as follows: Votes For Votes Against Abstentions 7,681,932 87,554 28,592View on SEC.gov
Dermata Therapeutics, Inc. shareholders approved Adoption and approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio from one-for-two to one-for-forty, with the exact ratio determined by the board at the 2023-02-08 meeting.
Proposal No. 1 : The Reverse Stock Split Proposal was approved by a vote of stockholders as follows: Votes For Votes Against Abstentions 7,622,928 135,481 39,669View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.